Cardiac complications in Behçet's disease

Clinical and Experimental Dermatology

Volumn 27, Issue 8, 2002, Pages 651-653

  Tursen U ^a,b   Ulubas B ^a   Irfan Kaya, T ^a   Pekdemir, H ^a   Ikizoglu G ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; FIBRINOLYTIC AGENT; STREPTOKINASE; TRIAMCINOLONE ACETONIDE; WARFARIN;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FOLLOW UP; HEART DISEASE; HUMAN; LABORATORY TEST; LUNG EMBOLISM; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN EXAMINATION; THROMBUS; TREATMENT OUTCOME;

ADULT; BEHCET SYNDROME; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS; MALE; THROMBOSIS;

EID: 18744385210     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.01090.x     Document Type: Article

References (16)

1. International Study Group for Behçet's Disease Contributors. Evaluation of diagnostic ('classification') criteria in Behçet's Disease: Toward internationally agreed criteria. In: O'Duffy JD, Kökmen E, eds. Behçet's Disease Basic and Clinical Aspects. New York: Marcel Dekker Inc., 1991: 11-39.
2. Behçet H. Uber rezidivierende aphthouse durch ein virus verursachte geschwuere am mund, am auge und an den genitalien. Dermatol Monatsschr Wochenschr 1937; 105: 1152-7.
3. Gurler A, Boyvat A, Tursen U. Clin manifestations of Behçet's disease: An pnalysis of 2147 patients. Yonsei Med J 1997; 38: 423-7.
4. Akpek G et al. Vascular involvement in Behçet's disease. J Rhematol 1992; 19: 402-10.
5. Ozkan M, Emel O, Özdemir M et al. M-mode, 2-D and Doppler echocardiography study in 65 patients with Behçet's disease. Eur Heart J 1992; 13: 638-41.
6. Mendes LA, Magraw LL, Aldea GS, Davidoff R. Right ventricular thrombus. An unusual manifestation of Behçet's disease. J Am Soc Echocardiogr 1994; 7: 438-40.
7. Moǧolkoç N, Burgess MI, Bishop PW. Intracardiac thrombus in Behçet's disease. Chest 2000; 118: 479-87.
8. Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 1997; 14: 1-10.
9. Yazici H, Tüzün Y, Pazarli H et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestation of Behçet's syndrome. Ann Rheum Dis 1984; 43: 783-9.
10. Vaya A, Forner MJ, Estelles A et al. Intracardiac thrombosis in a case of Behçet's disease associated with the prothrombin 20210G-A mutation. Haematologica 2000; 85: 425-8.
11. Gehring NH, Frede U, Neu-Yilik G et al. Increased efficiency of mRNA-3′ end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nature Genet 2001; 28: 389-92.
12. Poort SR, Rosendeal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
13. Hillarp A, Zoller B, Svensson PJ, Dahlback B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990-2.
14. El-Ramahani KM, Fawzy ME, Sieck JO et al. Cardiac and pulmonary involvement in Behçet's disease. Scand J Rheumatol 1991; 20: 373-6.
15. Akar N, Misirlioglu M, Akar E et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998; 58: 249.
16. Tursen U, Kaya TI, Eskandari G et al. Association of factor V Leiden and prothombrin gene mutation with Behçet's disease. Arch Dermatol Res 2001; 293: 537-539.